Search Results

TPCA-1 10mM (in 1mL DMSO)  | 99.32%

APEXBIO TECHNOLOGY LLC

IKK-2 inhibitor,potent and selective Immunology/Inflammation|IκB/IKK

More Information Supplier Page

×

TPCA-1

TPCA-1 5mg  | 99.32%

APEXBIO TECHNOLOGY LLC

IKK-2 inhibitor,potent and selective Immunology/Inflammation|IκB/IKK

More Information Supplier Page

×

TPCA-1

TPCA-1 10mg  | 99.32%

APEXBIO TECHNOLOGY LLC

IKK-2 inhibitor,potent and selective Immunology/Inflammation|IκB/IKK

More Information Supplier Page

×

TPCA-1

TPCA-1 100mg  | 99.32%

APEXBIO TECHNOLOGY LLC

IKK-2 inhibitor,potent and selective Immunology/Inflammation|IκB/IKK

More Information Supplier Page

×

TPCA-1

SP 600125 10mM (in 1mL DMSO)  | 98%

APEXBIO TECHNOLOGY LLC

JNK1/2/3 inhibitor MAPK Signaling|JNK

More Information Supplier Page

×

SP 600125

Empagliflozin (BI 10773) 100mg  | 99.05%

APEXBIO TECHNOLOGY LLC

SGLT-2 inhibitor for oral treatment of type 2 diabetes Metabolism|SGLT

More Information Supplier Page

×

Empagliflozin (BI 10773)

Empagliflozin (BI 10773) 50mg  | 99.05%

APEXBIO TECHNOLOGY LLC

SGLT-2 inhibitor for oral treatment of type 2 diabetes Metabolism|SGLT

More Information Supplier Page

×

Empagliflozin (BI 10773)

Empagliflozin (BI 10773) 10mg  | 99.05%

APEXBIO TECHNOLOGY LLC

SGLT-2 inhibitor for oral treatment of type 2 diabetes Metabolism|SGLT

More Information Supplier Page

×

Empagliflozin (BI 10773)

Empagliflozin (BI 10773) 5mg  | 99.05%

APEXBIO TECHNOLOGY LLC

SGLT-2 inhibitor for oral treatment of type 2 diabetes Metabolism|SGLT

More Information Supplier Page

×

Empagliflozin (BI 10773)

Empagliflozin (BI 10773) 10mM (in 1mL DMSO)  | 99.05%

APEXBIO TECHNOLOGY LLC

SGLT-2 inhibitor for oral treatment of type 2 diabetes Metabolism|SGLT

More Information Supplier Page

×

Empagliflozin (BI 10773)